This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Nov 8;384(9955):1649-51.

doi: 10.1016/S0140-6736(14)61174-0. Epub 2014 Jul 28.

Alemtuzumab induction therapy in kidney transplantation

Dirk R J Kuypers¹

Affiliations

PMID: 25078307
DOI: 10.1016/S0140-6736(14)61174-0

Comment

Alemtuzumab induction therapy in kidney transplantation

Dirk R J Kuypers. Lancet. 2014.

. 2014 Nov 8;384(9955):1649-51.

doi: 10.1016/S0140-6736(14)61174-0. Epub 2014 Jul 28.

Author

Dirk R J Kuypers¹

Affiliation

¹ Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven B-3000, Belgium. Electronic address: dirk.kuypers@uzleuven.be.

PMID: 25078307
DOI: 10.1016/S0140-6736(14)61174-0

No abstract available

PubMed Disclaimer

Comment on

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
3C Study Collaborative Group; Haynes R, Harden P, Judge P, Blackwell L, Emberson J, Landray MJ, Baigent C, Friend PJ. 3C Study Collaborative Group, et al. Lancet. 2014 Nov 8;384(9955):1684-90. doi: 10.1016/S0140-6736(14)61095-3. Epub 2014 Jul 28. Lancet. 2014. PMID: 25078310 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information